Claritev vs Phreesia
CTEV and PHR side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CTEV and PHR compare
Phreesia is the larger company, worth 1.7 times as much as Claritev ($795M against $478M).
Phreesia grew revenue faster over the last twelve months (12.9% versus 6.9% for Claritev).
Phreesia keeps more of each dollar of sales as profit, with a net margin of 2.1% compared with −27.1% at Claritev.
Phreesia scores higher on the StockData Score (8 against 4 for Claritev), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CTEV | PHR |
|---|---|---|
| Size and price | ||
| Market cap | $478M | $795M |
| Share price | $28.21 | $12.81 |
| Change, 1 year | −51.2% | −43.4% |
| Change, 5 years | −80.0% | −81.1% |
| Beta (5Y) | 1.24 | 1.53 |
| Employees | 3,000 | 1,789 |
| StockData Score | ||
| Total score | 4 | 8 (better) |
| Valuation score | 1 | 1 |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 1 |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 75.4× |
| P/S | 0.5× (better) | 1.6× |
| P/B | – | 2.1× |
| EV/EBITDA | 118× | 15.8× (better) |
| P/FCF | – | 9.8× |
| FCF yield | −5.8% | 10.2% (better) |
| Fair value | – | $9.74 |
| Margin of safety | – | −31.6% |
| Growth | ||
| Revenue growth (TTM) | 6.9% | 12.9% (better) |
| Revenue growth, 5Y average | 0.58% | 26.4% (better) |
| Profitability | ||
| Gross margin | 72.8% | 85.4% (better) |
| Operating margin | 4.2% (better) | 2.5% |
| Net margin | −27.1% | 2.1% (better) |
| FCF margin | −2.7% | 15.9% (better) |
| Return on equity | – | 3.1% |
| Return on invested capital | 0.78% | 4.4% (better) |
| Financial health | ||
| Debt / equity | – | 0.18 |
| Net debt / EBITDA | 107.00 (better) | −0.16 |
| Interest coverage | 0.1× | 1.2× (better) |
| Current ratio | 1.15 | 1.76 (better) |
| Altman Z-score | −0.47 | 1.07 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | −0.38% | – |
| Shareholder yield | −0.38% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 91.0% | 94.0% |
| Held by insiders | 50.2% | 22.7% |
| Insider net buying, 12 months | $4.0M | $26.8M (better) |
| Short interest, % of float | 9.1% | 6.3% |
Go deeper
- CTEV stock overview
- CTEV income statement
- CTEV valuation and score
- PHR stock overview
- PHR income statement
- PHR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.